recomBlot Borrelia canis
Immunoblot tests for the detection of IgG or IgM antibodies
against Borrelia burgdorferi in serum or plasma in dogs
against Borrelia burgdorferi in serum or plasma in dogs
Mikrogen recomBlot Borrelia canis tests are line immunoassays for the detection and identification of IgM and IgG antibodies of all three genospecies (Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii) on one test strip.
- VlsE of different genospecies
- OspC of all genospecies and different B. garinii strain
Products
Advantages
- High sensitivity and specificity due to the use of recombinant immunodominant antigens:
| Antigen | Strain |
| p100 | B. afzelii |
| VIsE | different Borrelia genospecies |
| p41 | B. burgdorferi sensu stricto |
| p39 | B. afzelii |
| OspA | B. afzelii |
| OspC | B. burgdorferi sensu stricto, B. afzelii, B. garinii, B. bavariensis |
| p41/intern | B. afzelii, B. garinii |
| p18 | B. afzelii |
- Separate detection of IgG and IgM antibodies
- Simple and clear interpretation due to easily readable bands
- Optimal presentation without cross-reacting Borrelia proteins
- Standardized serum liquor analysis possible
- Ideal complement as confirmatory test to the recomWell Borrelia tests
- Partial automation possible
Safe and reliable
Validity check by integrated antibody class controls
Flexible and compatible
Combination of all microgene recomBlot possible - uniform processing and interchangeable reagents
Standard
CE mark: The recomBlot Borrelia Canis Test fulfils the requirements of the EC Directive 98/79/EC for in vitro diagnostic medical devices.